Combined exposure of sotrastaurin with alpelisib, a selective PI3K-alpha inhibitor, resulted in synergistic cell death in GNAQ and GNA11 mutant uveal melanoma cell lines and tumor growth inhibition in a GNAQ-mutant xenograft tumor model. The gene discussed is GNA11; the disease is uveal melanoma.